Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HF.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.517NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.427 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429 (Epsilon)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.334NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.302NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.222NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.434NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.467NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.9 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.277NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used